DrugJan 14, 2026
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets recall — FDA D-0255-2026
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Class IIFDA: OngoingSpecGx, LLC
Recall history in this database
Classification mix: Class II: 1.
Understanding this recall history
This page summarizes recall records in which the official source identifies SpecGx, LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.